J L Ferrero

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3K citations

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +7

First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's disease

J L Ferrero, Leslie Williams, Heather Stella et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2016 · 176 citations · Full text

Thrombospondin-1 Mimetic Peptide Inhibitors of Angiogenesis and Tumor Growth:  Design, Synthesis, and Optimization of Pharmacokinetics and Biological Activities

Fortuna Haviv, Michael F. Bradley, Douglas Kalvin et al. · Journal of Medicinal Chemistry · 2005 · 138 citations

Peptide 1, Immunology, Biological Activities +19

Metabolism and disposition of clarithromycin in man.

J L Ferrero, Barbara A. Bopp, Kennan C. Marsh et al. · Drug Metabolism and Disposition · 1990 · 135 citations

In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices.

A. David Rodrigues, Darcy J. Mulford, R D Lee et al. · Drug Metabolism and Disposition · 1995 · 70 citations